IT202000006256A1 - CALMING SYRUP - Google Patents
CALMING SYRUP Download PDFInfo
- Publication number
- IT202000006256A1 IT202000006256A1 IT102020000006256A IT202000006256A IT202000006256A1 IT 202000006256 A1 IT202000006256 A1 IT 202000006256A1 IT 102020000006256 A IT102020000006256 A IT 102020000006256A IT 202000006256 A IT202000006256 A IT 202000006256A IT 202000006256 A1 IT202000006256 A1 IT 202000006256A1
- Authority
- IT
- Italy
- Prior art keywords
- syrup
- fruit
- polydextrose
- cassava
- rice
- Prior art date
Links
- 235000020357 syrup Nutrition 0.000 title claims description 68
- 239000006188 syrup Substances 0.000 title claims description 68
- 230000001914 calming effect Effects 0.000 title claims description 11
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 32
- 235000013399 edible fruits Nutrition 0.000 claims description 17
- 230000002641 glycemic effect Effects 0.000 claims description 17
- 229920001100 Polydextrose Polymers 0.000 claims description 16
- 235000013856 polydextrose Nutrition 0.000 claims description 16
- 239000001259 polydextrose Substances 0.000 claims description 16
- 229940035035 polydextrose Drugs 0.000 claims description 16
- 240000003183 Manihot esculenta Species 0.000 claims description 12
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 240000007594 Oryza sativa Species 0.000 claims description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims description 10
- 235000009566 rice Nutrition 0.000 claims description 10
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 8
- 230000000144 pharmacologic effect Effects 0.000 claims description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 7
- 235000021014 blueberries Nutrition 0.000 claims description 7
- 235000020442 apple syrup Nutrition 0.000 claims description 6
- 235000013339 cereals Nutrition 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- 230000000202 analgesic effect Effects 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 230000002085 persistent effect Effects 0.000 claims description 4
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 239000008240 homogeneous mixture Substances 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 10
- 239000000835 fiber Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 244000078534 Vaccinium myrtillus Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000001339 gustatory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 208000000399 Procedural Pain Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Description
DOMANDA DI BREVETTO PER INVENZIONE INDUSTRIALE DAL TITOLO: PATENT APPLICATION FOR INDUSTRIAL INVENTION WITH THE TITLE:
SCIROPPO CALMANTE CALMING SYRUP
CAMPO DELL?INVENZIONE FIELD OF INVENTION
La presente invenzione si riferisce al campo delle composizioni alimentari. The present invention relates to the field of food compositions.
STATO DELL?ARTE STATE OF THE ART
La terapia antalgica non farmacologica comprende molti tipi d?intervento assai diversi fra loro, che tendono a modificare molti di quei fattori che aumentano o rendono pi? angosciante e drammatica la sensazione dolorosa. La ricerca conferma l?efficacia delle Tecniche Non Farmacologiche (TNF) per il trattamento del dolore pediatrico-neonatale, di origine sia organica che funzionale. Tali tecniche vengono adottate, soprattutto per le procedure diagnostico terapeutiche minori (prelievo di sangue, iniezioni, catetere ombelicale, catetere percutaneo, rimozione suture, visita oculistica, biopsia cutanea, puntura lombare). The non-pharmacological analgesic therapy includes many types of intervention very different from each other, which tend to modify many of those factors that increase or make more? the painful sensation is distressing and dramatic. Research confirms the effectiveness of Non-Pharmacological Techniques (TNF) for the treatment of pediatric-neonatal pain, of both organic and functional origin. These techniques are used, especially for minor diagnostic and therapeutic procedures (blood sampling, injections, umbilical catheter, percutaneous catheter, suture removal, eye examination, skin biopsy, lumbar puncture).
Gli interventi non farmacologici possono essere sostanzialmente distinti in: Non-pharmacological interventions can be substantially divided into:
? di supporto e relazione (sostengono e danno forza al bambino e alla famiglia); ? cognitivi (influenzano i pensieri del bambino); ? support and relationship (support and give strength to the child and the family); ? cognitive (affect the child's thoughts);
? comportamentali (modificano i comportamenti); ? behavioral (modify behaviors);
? fisici (interessano il sistema sensoriale). ? physical (affecting the sensory system).
La scelta della tecnica deve essere fatta in base a diversi fattori: et? del bambino/neonato, situazione clinica, tipologia del dolore, capacit? e volont? di collaborazione del bambino, risorse e competenze disponibili. Spesso si utilizza un approccio multimodale, adeguandolo alle caratteristiche individuali del piccolo paziente e alle esigenze cliniche del caso. The choice of technique must be made on the basis of several factors: age? of the child / newborn, clinical situation, type of pain, capacity? and will? collaboration of the child, resources and skills available. A multimodal approach is often used, adapting it to the individual characteristics of the small patient and to the clinical needs of the case.
Nel neonato le tecniche non farmacologiche (TNF) analgesiche sono approcci profilattici e complementari che riducono e talvolta aboliscono risposte di tipo algico nel neonato. In the neonate, analgesic non-pharmacological techniques (TNFs) are prophylactic and complementary approaches that reduce and sometimes abolish pain-like responses in the newborn.
Tra le tecniche non farmacologiche, vi sono: Among the non-pharmacological techniques, there are:
- Modificazioni ambientali (luci soffuse, rumori ridotti, concentrazione degli interventi di nursing, manipolazioni delicate, rispetto del riposo, limitazione delle procedure dolorose o stressanti). - Environmental changes (soft lighting, reduced noise, concentration of nursing interventions, delicate manipulations, respect for rest, limitation of painful or stressful procedures).
- Contatto pelle a pelle - Skin to skin contact
- Succhiotto (utilizzare il succhiotto prima e durante l?esecuzione delle manovre dolorose. Il succhiotto determina una stimolazione sensoriale e una distrazione dallo stimolo doloroso, pertanto efficace nel ridurre il dolore procedurale nel neonato). - Suzione non nutritiva mediante somministrazione di sostanze edulcorate. - Pacifier (use the pacifier before and during the execution of painful maneuvers. The pacifier causes sensory stimulation and distraction from the painful stimulus, therefore effective in reducing procedural pain in the newborn). - Non-nutritive sucking by administering sweetened substances.
La suzione non nutritiva agisce sul comportamento esercitando un effetto calmante, riducendo la frequenza cardiaca e la spesa metabolica ed elevando la soglia del dolore. L?efficacia analgesica del glucosio (concentrazione 30-33%, quantit? 0,1-1 ml per bocca) o del saccarosio (concentrazione dal 24% al 50%, quantit? 0,1-2 ml per bocca) 1 o 2 minuti prima della procedura dolorosa riduce o abolisce le risposte al dolore procedurale ed ha effetto calmante nelle situazioni di stress. Le soluzioni dolci (glucosate, saccarosio al 33%), sono liquide ? spesso per l?operatore ? difficile poter somministrare il prodotto ad un neonato, soprattutto ad un neonato pretermine. Non-nutritive sucking acts on behavior by exerting a calming effect, reducing heart rate and metabolic expenditure and raising the pain threshold. The analgesic efficacy of glucose (concentration 30-33%, quantity 0.1-1 ml by mouth) or sucrose (concentration from 24% to 50%, quantity 0.1-2 ml by mouth) 1 or 2 minutes before the painful procedure reduces or abolishes procedural pain responses and has a calming effect in stressful situations. Are the sweet solutions (glucose, 33% sucrose) liquid? often for the operator? difficult to administer the product to a newborn, especially a preterm infant.
- Saturazione sensoriale - Sensory saturation
L?associazione combinata di tecniche non farmacologiche ? rappresentata da stimoli di diversa natura (tattile, gustativa, uditiva, visiva) che competono in maniera antagonista allo stimolo doloroso. La complessit? di stimoli come la voce, il controllo visivo, lo stimolo gustativo e la suzione di sostanza edulcorata agisce attraverso il Gate Control System, sistema che blocca l?arrivo dello stimolo doloroso alle aree corticali e di integrazione del cervello. The combined association of non-pharmacological techniques? represented by stimuli of different nature (tactile, gustatory, auditory, visual) which compete in an antagonistic way to the painful stimulus. The complexity? of stimuli such as the voice, the visual control, the gustatory stimulus and the sucking of sweetened substance act through the Gate Control System, a system that blocks the arrival of the painful stimulus to the cortical and integration areas of the brain.
Le soluzione edulcorate che vengono utilizzate nelle tecniche non farmacologiche, risultano essere liquide, questo comporta una difficolt? per la somministrazione della soluzione, poich? si dovr? stare attenti alla quantit? che si andr? a somministrare al neonato, questo porter? ad un maggior tempo per la somministrazione del prodotto e l?esecuzione della manovra diagnosticoterapeutica. Le soluzioni edulcorate inoltre presentano un indice glicemico elevato: glucosio (IG:100), saccarosio (IG:70). The sweetened solutions that are used in non-pharmacological techniques, turn out to be liquid, this involves a difficulty? for the administration of the solution, since? will you have to? be careful of the quantity? what will you go? to administer to the newborn, this porter? at a longer time for the administration of the product and the execution of the diagnostic-therapeutic maneuver. The sweetened solutions also have a high glycemic index: glucose (IG: 100), sucrose (IG: 70).
Da 70 in su l'indice glicemico ? considerato ALTO. From 70 upwards the glycemic index? considered HIGH.
Da 56 a 69 l'indice glicemico ? considerato MODERATO. From 56 to 69 the glycemic index? considered MODERATE.
Da 41 a 55 l'indice glicemico ? considerato BASSO. From 41 to 55 the glycemic index? considered LOW.
Fino a 40 l'indice glicemico ? considerato MOLTO BASSO. Up to 40 the glycemic index? considered VERY LOW.
Esiste in commercio uno sciroppo calmante descritto nel brevetto IT1368153, a nome della stessa richiedente, avente una consistenza (intesa come adesivit? e densit?) che ne permette l?applicazione e l?adesione per un tempo sufficiente su una superficie di materiale qualsivoglia (gomma, plastica, metallo, legno ecc.) come ad esempio: tettarelle di biberon, succhiotti, cucchiaini. Questo sciroppo dolce ? costutuito da There is on the market a calming syrup described in patent IT1368153, in the name of the same applicant, having a consistency (understood as adhesiveness and density) that allows its application and adhesion for a sufficient time on a surface of any material (rubber , plastic, metal, wood, etc.) such as: bottle teats, pacifiers, teaspoons. This sweet syrup? constituted by
Sciroppo di manioca 50% Cassava syrup 50%
Sciroppo di mele 23% Apple syrup 23%
Mirtillo fruttolisato 17% Fruity bilberry 17%
Sciroppo di riso 10% Rice syrup 10%
e presenta un IG di 50-51. and has a GI of 50-51.
Scopo della presente invenzione ? quello di fornire uno sciroppo calmante che presenti un indice glicemico ancora pi? basso. Purpose of the present invention? to provide a soothing syrup that has an even higher glycemic index? low.
SOMMARIO DELL?INVENZIONE SUMMARY OF THE INVENTION
La presente invenzione risolve i problemi suddetti mediante uno sciroppo calmante comprendente uno sciroppo di tuberi privi di glutine o deglutinati, uno sciroppo di frutta, uno sciroppo di cereali privi di glutine o deglutinati, un estratto di frutta e Polidestrosio. The present invention solves the above problems by means of a calming syrup comprising a syrup of gluten-free or swallowed tubers, a fruit syrup, a syrup of gluten-free or swallowed cereals, a fruit extract and polydextrose.
Sorprendentemente la presenza di polidestrosio contribuisce alla diminuzione dell?indice glicemico senza alterare la consistenza e il sapore. Surprisingly, the presence of polydextrose contributes to the decrease of the glycemic index without altering the texture and flavor.
Lo sciroppo dell?invenzione presenta un sapore gradevole e persistente, tale da poterlo utilizzare nelle tecniche non farmacologiche mirate alla riduzione degli stimoli dolorosi e di controllo del dolore nel neonato. Lo sciroppo calmante della presente invenzione ? utilizzato come sostanza dolce da somministrare per terapie antalgica non farmacologica. In particolare da somministrare al neonato, durante le manovre minori, per attenuare la sensazione di dolore durante le procedure diagniostico-terapeutico minori (prelievo di sangue, iniezioni, inserimento di canula...). Grazie alla sua adesivit?, lo sciroppo calmante potr? essere applicato sul succhietto, in questo modo sar? favorita sia la saturazione sensoriale (stimolazione gustativa) sia la suzione non nutritiva. The syrup of the invention has a pleasant and persistent taste, such that it can be used in non-pharmacological techniques aimed at reducing painful stimuli and controlling pain in the newborn. The soothing syrup of the present invention? used as a sweet substance to be administered for non-pharmacological analgesic therapies. In particular, to be administered to the newborn, during minor maneuvers, to alleviate the sensation of pain during minor diagnostic-therapeutic procedures (blood sampling, injections, cannula insertion ...). Thanks to its adhesiveness, the soothing syrup will be able to be applied on the soother, in this way it will be? both sensory saturation (gustatory stimulation) and non-nutritive sucking are favored.
Lo sciroppo calmante viene utilizzato come consolatore naturale, ci? ? possibile grazie al suo buon sapore, alla sua densit? ed adesivit?. Esso favorisce la consolazione del neonato irrequieto attraverso l'appagamento del gusto, utile a tutte le mamme durante le fasi del primo sonno: poche gocce applicate sul ciuccio o direttamente in bocca, consentono al beb? di rilassarsi e ne concilia il sonno. Calma il neonato ed ? pratico per i lunghi viaggi in auto. The soothing syrup is used as a natural comforter. ? possible thanks to its good flavor, its density? and adhesiveness. It favors the consolation of the restless newborn through the satisfaction of taste, useful for all mothers during the phases of the first sleep: a few drops applied on the pacifier or directly in the mouth, allow the baby? to relax and sleep. Calm the newborn and? practical for long car journeys.
DESCRIZIONE DETTAGLIATA DELL?INVENZIONE DETAILED DESCRIPTION OF THE INVENTION
Ai fini della presente invenzione per tuberi privi di glutine o deglutinati si intendono: tapioca, manioca, patata. Preferibilmente lo sciroppo dell?invenzione comprende sciroppo di manioca. For the purposes of the present invention, gluten-free or swallowed tubers mean: tapioca, cassava, potato. Preferably the syrup of the invention comprises cassava syrup.
Ai fini della presente invenzione per cereali privi di glutine si intendono mais, riso. Preferibilmente lo sciroppo dell?invenzione comprende sciroppo di riso. For the purposes of the present invention, gluten-free cereals mean corn, rice. Preferably the syrup of the invention comprises rice syrup.
Ai fini della presente invenzione per sciroppo di frutta si intende quello ottenuto da qualsiasi tipo di frutta e preferibilmente mela, pera, arancia, susina. Preferibilmente lo sciroppo dell?invenzione comprende sciroppo di mela. For the purposes of the present invention, fruit syrup is meant that obtained from any type of fruit and preferably apple, pear, orange, plum. Preferably the syrup of the invention comprises apple syrup.
Ai fini della presente invenzione per estratto di frutta s?intende il succo di frutta in generale, il prodotto ottenuto per lisi delle cellule di frutti, ed altri simili. Preferibilmente lo sciroppo dell?invenzione comprende fruttolisato di mirtillo. For the purposes of the present invention, by fruit extract is meant fruit juice in general, the product obtained by lysis of fruit cells, and other similar ones. Preferably the syrup of the invention comprises blueberry fructolysate.
Le fibre alimentari sono dei carboidrati, polimeri con tre o pi? unit? monomeriche che non vengono idrolizzati dagli enzimi endogeni dell?intestino tenue umano. Le fibre alimentari sono un gruppo di sostanze molto eterogeneo con una caratteristica in comune: a causa della loro struttura chimica, non vengono n? digerite, n? assorbite dall?intestino tenue. Questa loro peculiarit? ? unica, dato che invece le proteine, i glucidi e i lipidi vengono assorbiti nel tenue e forniscono energia. Le fibre alimentari possono essere di tipo diverso, possono essere: funzionali, viscose e non viscose, solubili e non solubili, fermentabili e non fermentabili. In natura e in commercio esistono diversi tipi di fibre. Dietary fibers are carbohydrates, polymers with three or more? unit? monomeric that are not hydrolyzed by the endogenous enzymes of the human small intestine. Dietary fibers are a very heterogeneous group of substances with one characteristic in common: due to their chemical structure, they do not come n? digest, n? absorbed from the small intestine. This their peculiarity? ? unique, since instead proteins, carbohydrates and lipids are absorbed in the small intestine and provide energy. Dietary fibers can be of different types, they can be: functional, viscous and non-viscous, soluble and non-soluble, fermentable and non-fermentable. In nature and on the market there are different types of fibers.
Lo sciroppo calmante della presente invenzione contiene una fibra ad azione funzionale che oltre a ridurre l?indice glicemico del prodotto ha anche permesso al prodotto stesso di mantenere lo stesso sapore gradevole, colore e le stesse propriet? organolettiche (adesivit? e densit?). The calming syrup of the present invention contains a fiber with a functional action which, in addition to reducing the glycemic index of the product, has also allowed the product itself to maintain the same pleasant taste, color and the same properties. organoleptic (adhesiveness and density).
L?uso del polidestrosio ha permesso di ridurre l?indice glicemico dello sciroppo calmante, mantenendo la giusta consistenza (intesa come adesivit? e densit?) che ne permette l?applicazione e l?adesione per un tempo sufficiente su una superficie di materiale diverso (gomma, plastica, silicone, etc.) come ad esempio: tettarella di biberon, succhiotti, cucchiaini etc? Il polidestrosio, ? un polisaccaride sintetico ricavato da destrosio, sorbitolo e acido citrico, costituito da fibra solubile per circa il 90 %. Il polidestrosio ? una fibra solubile a basso contenuto calorico che viene utilizzato nell?industria alimentare come dolcificante e per fornire corpo e consistenza agli alimenti. The use of polydextrose has made it possible to reduce the glycemic index of the calming syrup, maintaining the right consistency (understood as adhesiveness and density) which allows its application and adhesion for a sufficient time on a surface of different material ( rubber, plastic, silicone, etc.) such as: baby bottle teat, pacifiers, teaspoons etc? Polydextrose,? a synthetic polysaccharide obtained from dextrose, sorbitol and citric acid, consisting of about 90% soluble fiber. Polydextrose? a low calorie soluble fiber that is used in the food industry as a sweetener and to provide body and texture to foods.
Il Polidestrosio, rispetto ad altre fibre ha un sapore dolce, colore giallo chiaro, motivo che ha portato la scelta nell?utilizzarlo come ingrediente nella formulazione dello sciroppo calmante della presente invenzione. Il Polidestrosio, fra le varie sostanze tesate, ? stata l?unica fibra a non aver alterato il sapore, colore e le propriet? organolettiche (viscosit? ed adesivit?) dello sciroppo calmante, inoltre l?aggiunta di esso ha permesso una riduzione dell?indice glicemico. Altre fibre testate non avevano prodotto alcuna diminuzione dell?indice glicemico. Polydextrose, compared to other fibers has a sweet taste, a light yellow color, a reason that led to the choice in using it as an ingredient in the formulation of the calming syrup of the present invention. Polydextrose, among the various substances tested,? was the only fiber not to have altered the flavor, color and properties? organoleptic properties (viscosity and adhesiveness) of the soothing syrup, furthermore the addition of it has allowed a reduction of the glycemic index. Other fibers tested did not produce any decrease in the glycemic index.
Lo sciroppo della presente invenzione ? preferibilmente costituito da The syrup of the present invention? preferably consisting of
Sciroppo di tuberi 23?62% Tuber syrup 23 - 62%
Sciroppo di frutti 18?25% Fruit syrup 18-25%
Estratto di frutti 10?25% Fruit extract 10-25%
Polidestrosio 7-15% Polydextrose 7-15%
Sciroppo di cereali 5-13% 5-13% cereal syrup
in cui le % sono in peso rispetto al peso totale della composizione. in which the% are by weight with respect to the total weight of the composition.
Lo sciroppo calmante della presente invenzione ? preferibilmente costituito da sciroppo di manioca, sciroppo di riso, sciroppo di mele, mirtillo fruttolisato e polidestrosio. The soothing syrup of the present invention? preferably consisting of cassava syrup, rice syrup, apple syrup, fruity blueberry and polydextrose.
Lo sciroppo calmante della presente invenzione presenta preferibilmente la seguente composizione: The calming syrup of the present invention preferably has the following composition:
Sciroppo di manioca 40-45%; pi? preferibilmente 42 % Cassava syrup 40-45%; pi? preferably 42%
Sciroppo di mele 20-25%; pi? preferibilmente 23 % Apple syrup 20-25%; pi? preferably 23%
Fruttolisato di mirtillo 15-20%; pi? preferibilmente 17 % Fructolysate of blueberry 15-20%; pi? preferably 17%
Polidestrosio 8-12%; pi? preferibilmente 10 % Polydextrose 8-12%; pi? preferably 10%
Sciroppo di riso 6-10%; pi? preferibilmente 8 % Rice syrup 6-10%; pi? preferably 8%
in cui le % sono in peso rispetto al peso totale della composizione. in which the% are by weight with respect to the total weight of the composition.
L?inserimento del Polidestrosio ha conferito allo sciroppo della presente invenzione un indice glicemico di 47-48 producendo, rispetto allo sciroppo noto allo stato dell?arte una riduzione del 6% dell?Indice glicemico. The insertion of polydextrose has given the syrup of the present invention a glycemic index of 47-48, producing, compared to the syrup known in the state of the art, a reduction of 6% in the glycemic index.
La preparazione dello sciroppo avviene nel seguente modo: The preparation of the syrup takes place in the following way:
pesare separatamente ogni singolo ingrediente; weigh each single ingredient separately;
porre ogni singolo ingrediente pesato all?interno di un contenitore dotato di agitatore; place each single ingredient weighed in a container equipped with a stirrer;
mescolare a temperatura ambiente i componenti per almeno 20 minuti fino ad ottenere una miscela omogenea. mix the components at room temperature for at least 20 minutes until a homogeneous mixture is obtained.
Lo sciroppo cos? ottenuto avr? un sapore gradevole, persistente e con un basso Indice glicemico, potr? essere utilizzato, grazie anche alla sua consistenza ed adesivit?, su superfici di diverso materia: gomma, silicone, caucci?, etc, La consistenza e l?adesivit? dello sciroppo calmante favorir? un persistente sapore dolce in bocca e far? s? che possano essere utilizzate solamente una o due gocce al momento del bisogno, ad esempio prima e/o durante una procedura diagnostico terapeutica minore su un neonato, per cui non ? previsto un trattamento farmacologico per ridurre la percezione del dolore, ci? aiuter? la somministrazione da parte dell?operatore sanitario che dovr? eseguire l?esame, perch? dovr? utilizzare solo 1 o 2 gocce di sciroppo calmante, inoltre lo potr? effettuare con tranquillit? in quanto l?indice glicemico dello sciroppo ? molto basso. The syrup cos? got avr? a pleasant flavor, persistent and with a low glycemic index, can? be used, thanks also to its consistency and adhesiveness, on surfaces of different materials: rubber, silicone, caoutchouc ?, etc, The consistency and the adhesiveness? of the soothing syrup favorir? a persistent sweet taste in the mouth and let? s? that only one or two drops can be used when needed, for example before and / or during a minor diagnostic therapeutic procedure on a newborn, so not? provided a drug treatment to reduce the perception of pain, there? will help? the administration by the health care worker who will have to? perform the exam, why? will I have to? use only 1 or 2 drops of soothing syrup, in addition it will be able to? carry out with tranquility? in what is the glycemic index of the syrup? very low.
PARTE SPERIMENTALE ESEMPIO 1 EXPERIMENTAL PART EXAMPLE 1
Sono state eseguite diverse prove con materie prime ad indice glicemico nullo per cercare una nuova formulazione a partire da quella descritta in IT1368153, Several tests were carried out with raw materials with a null glycemic index to look for a new formulation starting from the one described in IT1368153,
Al termine di tali prove ? stato identificato il POLIDESTROSIO come materia prima ottimale. At the end of these tests? POLYDESTROSIUM has been identified as an optimal raw material.
ESEMPIO 2 ? Preparazione di uno sciroppo secondo l?invenzione EXAMPLE 2? Preparation of a syrup according to the invention
Ogni singolo ingrediente viene pesato separatamente: Each single ingredient is weighed separately:
- 50 kg sciroppo di manioca (SIOA-PIOCA-69 SIPAL) - 50 kg cassava syrup (SIOA-PIOCA-69 SIPAL)
- 8 kg DI Sciroppo di riso (SIPA ? RICA ? 62 sipal) - 8 kg of rice syrup (SIPA? RICA? 62 sipal)
- 17 kg di Fructolysato di mirtillo (Amitalia) - 17 kg of blueberry fructolysato (Amitalia)
- 23 kg concentrato di mele 99% (Galeno ? Urlich) - 23 kg apple concentrate 99% (Galen? Urlich)
- 10 kg Polidestrosio (STA-LITE L90). - 10 kg Polydextrose (STA-LITE L90).
Poi vengono posti all?interno di un contenitore dotato di agitatore. I componenti vengono mescolati fino ad ottenere una omogenea miscelazione (circa 30 minuti), il tutto viene effettuato ad una temperatura ambiente. La miscela cos? ottenuta ? ripartita in opportuni flaconi in PET con tappo contagocce. Then they are placed inside a container equipped with a stirrer. The components are mixed until a homogeneous mixing is obtained (about 30 minutes), all carried out at room temperature. The mixture so? obtained? divided into suitable PET bottles with dropper cap.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000006256A IT202000006256A1 (en) | 2020-03-25 | 2020-03-25 | CALMING SYRUP |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000006256A IT202000006256A1 (en) | 2020-03-25 | 2020-03-25 | CALMING SYRUP |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202000006256A1 true IT202000006256A1 (en) | 2021-09-25 |
Family
ID=70978377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102020000006256A IT202000006256A1 (en) | 2020-03-25 | 2020-03-25 | CALMING SYRUP |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202000006256A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004065707A (en) * | 2002-08-08 | 2004-03-04 | Taro Kawasaki | Pacifier for baby and little children and pacifier for baby and little children containing xylitol |
WO2004075664A1 (en) * | 2003-02-26 | 2004-09-10 | Danisco A/S | New use of polydextrose in edible products, edible products containing polydextrose and process for including polydextrose in edible products |
US20060110519A1 (en) * | 2004-11-19 | 2006-05-25 | Atkins Nutritionals, Inc. | Low-glycemic alcoholic beverages and methods for making same |
IT1368153B1 (en) | 2006-05-10 | 2009-12-01 | Inlinea S R L | SWEET SYRUP |
WO2017036488A1 (en) * | 2015-09-04 | 2017-03-09 | Urgo Recherche Innovation Et Developpement | Combination product for assisting with relaxation and sleep |
WO2019017800A1 (en) * | 2017-07-18 | 2019-01-24 | Punzalan A Emma | Palatable low-glycemic nutritional drink |
-
2020
- 2020-03-25 IT IT102020000006256A patent/IT202000006256A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004065707A (en) * | 2002-08-08 | 2004-03-04 | Taro Kawasaki | Pacifier for baby and little children and pacifier for baby and little children containing xylitol |
WO2004075664A1 (en) * | 2003-02-26 | 2004-09-10 | Danisco A/S | New use of polydextrose in edible products, edible products containing polydextrose and process for including polydextrose in edible products |
US20060110519A1 (en) * | 2004-11-19 | 2006-05-25 | Atkins Nutritionals, Inc. | Low-glycemic alcoholic beverages and methods for making same |
IT1368153B1 (en) | 2006-05-10 | 2009-12-01 | Inlinea S R L | SWEET SYRUP |
WO2017036488A1 (en) * | 2015-09-04 | 2017-03-09 | Urgo Recherche Innovation Et Developpement | Combination product for assisting with relaxation and sleep |
WO2019017800A1 (en) * | 2017-07-18 | 2019-01-24 | Punzalan A Emma | Palatable low-glycemic nutritional drink |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105660791A (en) | Infant molar rod biscuit containing soybean dietary fibers and production method thereof | |
Pinneau | A critique on the articles by Margaret Ribble | |
Shiff et al. | Psychosocial and neurobiological vulnerabilities of the hospitalized preterm infant and relevant non-pharmacological pain mitigation strategies | |
CA2958712C (en) | Slowly digestible, sustained-type energy supplying agent | |
Osinaike et al. | Effect of breastfeeding during venepuncture in neonates | |
IT202000006256A1 (en) | CALMING SYRUP | |
Akcam et al. | Oral hypertonic glucose spray: a practical alternative for analgesia in the newborn | |
Solter | Why do babies cry? | |
CN101785854B (en) | Lutein multivitamin nutrition health care medicine composition and preparation method and applications thereof | |
WO2019046440A1 (en) | Compositions and methods for cognitive, immune and digestive support in patients with autism spectrum disorder | |
Singh | Effectiveness of coconut oil massage on weight gain among low birth weight newborns | |
Hess | Feeding and the nutritional disorders in infancy and childhood | |
Hess | Feeding and the nutritional disorders in infancy and childhood | |
RU2609874C1 (en) | Alcohol-free beverage "complete amino liquid" | |
Akai | Dysphagia rehabilitation manual | |
Molin et al. | Serum IgE in mycosis fungoides. | |
Abed Elataief et al. | Effect of Massage Therapy on Vital Signs of Premature Infant at Neonatal Intensive Care Unitsin Sohag city | |
Rodin | Stress-induced eating: Implications for diabetes | |
Lipsitt | Assessment of sensory and behavioral functions in infancy | |
Janani et al. | A simple febrile seizure presented with pneumococcal meningitis with negative blood culture result. | |
Wright et al. | Neonatal abstinence syndrome. | |
Kavthekar et al. | Comparison of 24% sucrose as analgesic during 2nd and 3rd diphtheria-pertussis-tetanus vaccinations with 1st diphtheria-pertussis-tetanus vaccination | |
Khan et al. | ANALGESIC EFFECT OF SUCROSE OBSERVED DURING HEEL PRICK IN HEALTHY NEONATES: Analgesic Effects of Sucrose | |
Manuprakash et al. | Comparison of Pain Response to Heel Prick and Venepuncture in Term Babies. | |
CN115067504A (en) | Special medical food for intestinal tract preparation and preparation method thereof |